Chemerin levels in chronic kidney disease: A systematic review and meta-analysis

Amir Hossein Behnoush1,2, Parnian Shobeiri1,2,3,4, Pegah Bahiraie5

  • 1School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Frontiers in Endocrinology
|February 10, 2023
PubMed

Insights

This study found elevated chemerin levels in chronic kidney disease (CKD) patients, suggesting its potential as an inflammatory biomarker. Further research is needed to explore chemerin

Area of Science:

  • Biochemistry
  • Nephrology
  • Immunology

Background:

  • Chemerin is recognized for its role as an inflammatory biomarker.
  • Chronic kidney disease (CKD) is a significant global health concern associated with high mortality and morbidity.
  • Previous studies have explored chemerin levels in CKD patients, necessitating a comprehensive review.

Purpose of the Study:

  • To systematically review and meta-analyze the association between chemerin levels and chronic kidney disease.
  • To investigate chemerin as a potential biomarker in various stages of CKD, including end-stage renal disease.

Main Methods:

  • A systematic search was conducted across PubMed, Scopus, Embase, and Web of Science databases.
  • Studies comparing chemerin levels in CKD patients (including hemodialysis patients) with healthy controls were included.
  • Random effects meta-analysis was employed to calculate the standardized mean difference (SMD) and 95% confidence intervals (CI).

Main Results:

  • Eight studies involving 875 participants were analyzed, all demonstrating high quality.
  • Meta-analysis revealed significantly higher chemerin levels in CKD patients compared to healthy controls (SMD 2.15, 95% CI 0.83-3.48, p<0.01).
  • Hemodialysis patients also exhibited statistically higher chemerin levels than controls (SMD 2.10, 95% CI 0.58-3.62, p=0.01).

Conclusions:

  • Chemerin shows potential as a valuable biomarker for CKD, indicating underlying inflammatory pathways.
  • Further investigation is warranted to elucidate the clinical applications and pathophysiological role of chemerin in CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
66
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
53
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
57
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
38
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
131
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
41